Tag:
Cofactor
Latest Headlines
Latest Headlines
Adventrx ends enrollment, looks for partner
Adventrx Pharmaceuticals says it's closing enrollment in a late-stage study of CoFactor for metastatic colorectal cancer, following a recommendation by the data monitoring board to end enrollment due
